CODX · Co-Diagnostics, Inc. · Investor Relations
$1.08
+0.01 (+0.93%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because certain elements of management's plans to mitigate the conditions that raised substantial doubt about the Company's ability to continue as a going concern are outside of the Company's control, including the ability to raise capital through equity or other financings, those elements cannot be considered probable according to ASC 205-40, and therefore cannot be considered in the evaluation of mitigating factors. As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.82M
Shares
6.25M
Volume · Oct 1
105K
Avg daily vol (3M)
425.08K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-16 | Co-Diagnostics - Special Presentation | Presentation |
| 2026-08-13 | Co-Diagnostics, Inc. Second Quarter 2026 Earnings Webcast | Earnings call |
| 2026-05-14 | Co-Diagnostics, Inc. First Quarter 2026 Earnings Webcast | Earnings call |
| 2026-03-31 | Co-Diagnostics, Inc. Full Year 2025 Earnings Webcast | Earnings call |
Source: https://ir.co-dx.com/